GlassScriptPhysician profile
Lauren A Phillips
NPI 1023226719
$4,223.81
in general payments reported to CMS, 2019-2025
44 companies · $644 in 2025
The $644 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321 · 2020: $490 · 2021: $551 · 2022: $674 · 2023: $569 · 2024: $976 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,175 · Entertainment: $13.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,175.19 |
| Entertainment | $13.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $672.01 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $461.23 | 2023-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $299.76 | 2019-2025 | |
| Mayne Pharma Commercial LLC | $262.47 | 2021-2024 | |
| Sage Therapeutics, LLC | $259.88 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $214.58 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $205.48 | 2020-2025 | Slynd |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Caldera Medical, INC | $126.32 | 2024 | Desara |
| Myovant Sciences INC. | $122.79 | 2021-2022 | |
| Coopersurgical, INC. | $119.26 | 2019-2025 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $113.15 | 2019-2024 | Gardasil, Gardasil 9 |
| Hologic Sales and Service, LLC | $107.18 | 2019-2024 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Amgen INC. | $98.97 | 2019-2022 | |
| Radius Health, INC. | $95.73 | 2019-2025 | Tymlos |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $76.55 | 2022-2025 | Accrufer |
| Pfizer INC. | $68.53 | 2022-2024 | |
| Evofem Biosciences, INC. | $66.56 | 2021-2025 | Phexxi, Solosec, Phexx |
| Lupin INC. | $58.35 | 2020-2021 | |
| Organon LLC | $51.56 | 2023-2025 | Nexplanon |
| Exact Sciences Corporation | $50.71 | 2023-2025 | Cologuard Collection Kit |
| Mylan Pharmaceuticals INC. | $46.78 | 2019-2021 | |
| Baxter Healthcare | $44.79 | 2024 | Perclot |
| Aspira Women'S Health INC | $43.60 | 2020-2024 | Ova1 |
| Millicent US INC | $40.99 | 2025 | Femlyv |
| Biohaven Pharmaceutical Holding Company LTD. | $36.94 | 2022 | |
| Lsi Solutions INC | $33.51 | 2023 | Fornisee |
| Davol INC. | $26.71 | 2024 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $24.80 | 2023 | Pico 7 |
| Pacira Pharmaceuticals Incorporated | $23.70 | 2022 | |
| Roche Diagnostics Corporation | $21.72 | 2019 | |
| Dexcom, INC. | $21.00 | 2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $19.25 | 2023 | Truclear |
| Optumhealth Care Solutions, LLC | $19.02 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Supernus Pharmaceuticals, INC. | $17.68 | 2025 | Qelbree |
| Innovation Technologies INC | $16.87 | 2024 | Irrisept |
| Agile Therapeutics, INC. | $15.97 | 2022 | |
| Duchesnay USA Incorporated | $15.41 | 2019 | |
| Avion Pharmaceuticals | $14.75 | 2021 | |
| Argentum Medical | $13.04 | 2025 | |
| Medicem INC. | $12.55 | 2021 | |
| Medela LLC | $11.32 | 2020 | |
| Renovia INC | $11.19 | 2019 | |
| Dysis Medical, INC. | $11.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.